Investor's Business Daily on MSN3h
Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play; Will American Airlines Break Out? (Live Coverage)
Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...
Gilead, Vertex initiated as new big biotech buys at Citi
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
Why Vertex (VERX) Might be Well Poised for a Surge
Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MarketWatch1d
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity was originally published by The Motley Fool ...
Business Insider1d
Vertex price target raised to $62 from $50 at Morgan Stanley
Morgan Stanley analyst Chris Quintero raised the firm’s price target on Vertex (VERX) to $62 from $50 and keeps an Overweight rating on the shares. The firm has greater conviction in Vertex being a ...
Vertex’s Growth Potential and Raised Price Target Amidst ERP Supercycle and E-Invoicing Expansion
Vertex (VERX – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Chris Quintero from ...
Zacks.com on MSN6d
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...